Unlocking the Potential of C10orf71-AS1: A drug Target and Biomarker

Target Name: C10orf71-AS1

NCBI ID: G100506769

Other Name(s): C10orf71 antisense RNA 1

Unlocking the Potential of C10orf71-AS1: A drug Target and Biomarker

C10orf71-AS1, also known as ARID 1A, is a non-coding RNA (ncRNA) that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure, function, and bioavailability make it an attractive candidate for further research and development. In this article, we will explore the potential of C10orf71-AS1 as a drug target and biomarker, as well as its current status in the scientific community.

Potential Drug Target

C10orf71-AS1 has been shown to play a critical role in the development and progression of various diseases. Its functions in cell biology include regulating gene expression, modulating cellular signaling pathways, and modulating cellular response to environmental stimuli. C10orf71-AS1 has also been shown to interact with several protein targets, including TGF-β1, PDGF-BB, NF-kappa-B, and NF-ATFI. These interactions suggest that C10orf71-AS1 may be a potential drug target for diseases that are characterized by abnormalities in these signaling pathways.

Potential Biomarker

C10orf71-AS1 has also been shown to serve as a potential biomarker for various diseases. Its expression has been observed in a variety of tissues and fluids, including blood, urine, saliva, and breast tissue. Its expression has also been associated with several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique expression pattern and stability across different tissues make it a promising biomarker for these diseases.

Current Status

The study of C10orf71-AS1 is still in its infancy, and much research is needed to fully understand its potential as a drug target and biomarker. Several studies have investigated the effects of C10orf71-AS1 on cellular processes and have shown that it has promising properties as a drug target. For example, studies have shown that C10orf71-AS1 can inhibit the activity of the transcription factor TGF-β1 and can modulate the expression of genes involved in cell growth, apoptosis, and angiogenesis.

Conclusion

In conclusion, C10orf71-AS1 is a non-coding RNA that has the potential to be a drug target and biomarker for various diseases. Its unique structure, function, and bioavailability make it an attractive candidate for further research and development. Further studies are needed to fully understand its potential and to identify its potential drug targets and biomarkers. As research continues, we can expect to see new insights into the biology and use of C10orf71-AS1, and its potential as a therapeutic agent.

Protein Name: C10orf71 Antisense RNA 1

More Common Targets